Connect. Collaborate. Contribute.
JULY 2014
PLUS FEATURE FEATURE INSIGHT
J&J;'s Approach To Capturing
Disruptive Innovation
In Clinical Trials 26
The impetus for creating Janssen
Clinical Trial Innovation (CTI)
The Falsified Medicines
Directive — What Does
It Really Mean? 36
How countries around the world
are working to combat the influx
of fakes in the supply chain
Discovery Outsourcing 46
Outsourcing Insights 16
Capitol Perspectives 10
Companies To Watch 14
Avoiding Disruptive
Imbalances Between Industry
And Patient Foundations 32
Part II of BayBio's "Successful
Public-Private Partnerships"
survey insights
The Takeda Oncology
Michael Vasconcelles, M.D.,
global head, the Oncology Therapeutic Area
Unit, puts the company's past, present, and
future into context. p. 20
Millennium:
Strategic Direction
Company's Shift In
0 7 1 4 _ C o v e r _ F . i n d d 1 0714_Cover_F.indd 1 6 / 2 3 / 2 0 1 4 2 : 5 3 : 1 1 P M 6/23/2014 2:53:11 PM